SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Alnylam to Showcase Latest Data from TTR Franchise and Hypertension Program at American Heart Association Scientific Sessions 2024
October 30, 2024
 · 
5 min read
Press Releases
Ajax Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating AJ1-11095, a First-in-Class Type II JAK2 inhibitor, for the Treatment of Myelofibrosis
October 30, 2024
 · 
3 min read
Press Releases
OmniAb to Participate in Two Investor Conferences in November
October 30, 2024
 · 
2 min read
Press Releases
Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics
October 30, 2024
 · 
8 min read
Press Releases
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations
October 30, 2024
 · 
7 min read
Press Releases
Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024
October 30, 2024
 · 
1 min read
Press Releases
U.S. Food and Drug Administration (FDA) Grants Prolong Pharmaceuticals FDA Fast Track Designation for Novel Stroke Therapy (PP-007) in HEMERA-1 Clinical Study
October 30, 2024
 · 
3 min read
Press Releases
Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend
October 30, 2024
 · 
5 min read
Press Releases
Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30
October 30, 2024
 · 
3 min read
Press Releases
BrainTale Announces First Patient Enrolled in Investigator-Sponsored Prospective Multi-Centric Study CALDIFF to Clinically Validate One of Its Predictive Biomarkers
October 30, 2024
 · 
4 min read
Press Releases
Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
October 30, 2024
 · 
11 min read
Press Releases
BioIVT Launches LEUKOMAX® XL to Provide Researchers with More Cells from a Single Donor Collection per Volume
October 30, 2024
 · 
2 min read
Press Releases
ATCC Announces Subaward to Advance Research for Tickborne Diseases and Vaccine Development
October 30, 2024
 · 
3 min read
Press Releases
eLabNext Launches New Brand Positioning with Centralized Digital Lab Platform
October 30, 2024
 · 
3 min read
Press Releases
SynOx Therapeutics Adds New Investor and Capital to Series B Financing, Raising Total to $92 Million, and Doses First Patients in Phase 3 Trial
October 30, 2024
 · 
5 min read
Press Releases
Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update
October 30, 2024
 · 
15 min read
Press Releases
Atea Pharmaceuticals to Present New Data Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024
October 30, 2024
 · 
6 min read
Press Releases
Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results
October 30, 2024
 · 
13 min read
Press Releases
Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
October 30, 2024
 · 
18 min read
Press Releases
HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer
October 30, 2024
 · 
7 min read
Press Releases
MacroGenics Announces Leadership Transition
October 30, 2024
 · 
6 min read
Press Releases
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update
October 30, 2024
 · 
8 min read
Press Releases
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
October 30, 2024
 · 
7 min read
Press Releases
AbbVie Reports Third-Quarter 2024 Financial Results
October 30, 2024
 · 
28 min read
Press Releases
OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference
October 30, 2024
 · 
5 min read
Press Releases
Chemomab Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update
October 30, 2024
 · 
1 min read
Press Releases
KITHER BIOTECH ANNOUNCES PHASE 1 CLINICAL STUDY OF KIT2014, A NOVEL INHALED PEPTIDE THERAPY FOR CYSTIC FIBROSIS
October 30, 2024
 · 
3 min read
Press Releases
Neurocrine Biosciences Reports Third Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance
October 30, 2024
 · 
17 min read
Press Releases
I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024
October 30, 2024
 · 
2 min read
Press Releases
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
October 30, 2024
 · 
11 min read
Press Releases
Avanos Medical, Inc. Announces Third Quarter 2024 Results, retirement of CEO
October 30, 2024
 · 
27 min read
Press Releases
Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products
October 30, 2024
 · 
24 min read
Press Releases
Bausch + Lomb Announces Third-Quarter 2024 Results
October 30, 2024
 · 
19 min read
Press Releases
Novocure Reports Third Quarter 2024 Financial Results
October 30, 2024
 · 
11 min read
Load More